COVID-19 healthcare insights
Key COVID-19 issues facing the healthcare sector.
Showing 1 - 10 of 24
Advances in genomics are turbocharging the global response to the COVID-19 pandemic and continuing to redefine how we understand healthcare.
Our research identified five key risk themes that have implications and represent both challenges and opportunities for businesses, insurers, and wider society. This will assist in moving the conversation forward as we look beyond COVID-19, highlighting the important need to reshape the dynamic relationship between companies, households, and insurers.
From the Insurance Post Claims and Fraud summit 2020, in this video James Shrimpton, Partner at Kennedys, focuses on the legal basis for Covid-19 infection claims, current medical research, the impact of the pandemic on other injury claims and whether we will see a flood of infection claims.
Integrating new technology systems into large institutions is notoriously difficult even when it is carefully planned. So how has the rapid roll-out of telehealth during the pandemic altered the risk landscape?
The NHS’s commitment to a sustainable future: ‘net-zero’ and the role of technology, innovation and people
In its report ‘Delivering a ‘Net Zero’ National Health Service’ published on 1 October 2020, the NHS made the historic commitment to reduce its greenhouse gas emissions to net-zero by 2040 - the first national health service in the world to set such a goal – and set out its approach. This will require a major transformation: from the way the NHS provides care, to the types of medicines used and its supply chains, to how the NHS estate and supporting facilities services are managed.
As of 4 November 2020, individuals in England who are deemed “clinically extremely vulnerable” in relation to COVID-19 are advised to stay at home at all times, unless for exercise or doctors’ appointments, for the duration of the four week lockdown.
This year’s American Congress of Rehabilitation Medicine annual conference was itself an example of technological improvisation, with virtual delegates attending online due to the pandemic. One of the recurring themes of its numerous seminars was the medical necessity for reinvention of traditional rehabilitation models and the involuntary shift of providers towards caretech solutions for reasons of business continuity and infection control.
When countries with well-developed health systems scrambled to purchase life-saving ventilators at the start of the COVID-19 crisis it illustrated just how serious the pandemic would be. Working on a war footing, governments from France to Germany, the UK and the US asked industry to produce ventilators and personal protective equipment at speed.
Much has been learnt from the recent operational response to COVID-19 in terms of the way in which different healthcare providers have responded to the pandemic at short notice.
Best practice is slipping in clinical trials as the scientific community races to respond to Covid-19. Chubb and Kennedys consider the risks that are emerging as a result and how they can be mitigated.